Global Counterfeit Drug Detection Device Market Trends, Forecast Report 2025-2037
Counterfeit Drug Detection Device Market size was valued at USD 1.51 billion in 2024 and is likely to cross USD 2.99 billion by 2037, expanding at more than 5.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of counterfeit drug detection device is estimated at USD 1.58 billion.
The global counterfeit drug detection device market is witnessing expansion due to the increasing prevalence of counterfeit drugs, which pose strong risks to consumers' health and undermine the integrity of healthcare systems around the globe. Thus, as counterfeit medication becomes increasingly sophisticated and difficult to detect, the urgency grows for effective detection solutions that can be necessary and sufficient to assure patient safety and preserve public trust in pharmaceutical products.
To meet the demand gap, companies in the market are developing advanced technologies to detect counterfeit drugs. For instance, in March of 2023, InVita Healthcare Technologies launched Pharma Defense, the first-of-its-kind to focus specifically on testing counterfeits, a drug that will help gain the upper hand in the battle against pharmacy fraud. Additionally, governments across the world are implementing strict anti-counterfeit measures and investing in advanced detection technologies to ensure public health, thus fueling counterfeit drug detection device market growth.
